| 000 | 01425 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250517000502.0 | ||
| 264 | 0 | _c20150812 | |
| 008 | 201508s 0 0 eng d | ||
| 022 | _a1651-2081 | ||
| 024 | 7 |
_a10.2340/16501977-1895 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGrosset, Donald G | |
| 245 | 0 | 0 |
_aSwitch from abobotulinumtoxinA (Dysport®) to incobotulinumtoxinA (Xeomin®) botulinum toxin formulation: a review of 257 cases. _h[electronic resource] |
| 260 |
_bJournal of rehabilitation medicine _cFeb 2015 |
||
| 300 |
_a183-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBlepharospasm _xdrug therapy |
| 650 | 0 | 4 |
_aBotulinum Toxins, Type A _xadministration & dosage |
| 650 | 0 | 4 | _aCost Savings |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aDystonia _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemifacial Spasm _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intramuscular |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeuromuscular Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aTorticollis _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aTyrrell, Elaine G | |
| 700 | 1 | _aGrosset, Katherine A | |
| 773 | 0 |
_tJournal of rehabilitation medicine _gvol. 47 _gno. 2 _gp. 183-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2340/16501977-1895 _zAvailable from publisher's website |
| 999 |
_c24288037 _d24288037 |
||